| Name | 1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea |
|---|---|
| Synonyms |
FRENTIZOLE
1-(6-methoxybenzo[d]thiazol-2-yl)-3-phenylurea 1-(6-methoxy-2-benzothiazolyl)-3-phenylurea Frentizol 1-(6-methoxy-benzothiazol-2-yl)-3-phenyl-urea |
| Description | Frentizole, an FDA-approved immunosuppressive drug, is a novel inhibitor of the Aβ-ABAD interaction.IC50 value:Target: Aβ-ABAD interaction |
|---|---|
| Related Catalog | |
| References |
| Density | 1.42g/cm3 |
|---|---|
| Molecular Formula | C15H13N3O2S |
| Molecular Weight | 299.34800 |
| Exact Mass | 299.07300 |
| PSA | 94.98000 |
| LogP | 4.03550 |
| Index of Refraction | 1.752 |
| Storage condition | 2-8℃ |
| HS Code | 2934999090 |
|---|
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |